Skip to main content

Canaan Partners — Portfolio, Page 4

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

269
Companies
$8.1B
Total invested
$39.5M
Avg. check
52
Industries
Artificial Intelligence (AI) 6Biotechnology 6Health Care 5Medical 5Therapeutics 5Software 3+46 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 73–96 of 269
Field AI
February 2026

Field AI develops autonomy software that equips mobile robots with a universal, risk-aware brain.

Artificial Intelligence (AI) · Mission ViejoCorporate Round
Apex.AI
February 2025

Apex.AI specializes in software systems for robotic and autonomous vehicles.

Artificial Intelligence (AI) · Palo AltoSeries B
Tropic
February 2022

Tropic is a software platform that offers full-service procurement solutions for tech-forward companies.

Marketing · New York$40.0M Series B
Clutch
February 2025

Clutch is an online used vehicle retailer that enables customers to browse and purchase from a wide selection of pre-owned vehicles.

Automotive · Toronto$35.0M Series D
Journey Live
July 2025

Journey Live offers a preventative mental health solution to reduce turnover, tackle burnout, and help employees live healthier lives.

Fitness · New York$8.0M Series A
Gemist
June 2025

Gemist is the first-ever D2C custom jewelry company that allows consumers to design jewelry and try it on before they buy.

E-Commerce · Los Angeles$6.0M Seed
Actio Biosciences
June 2025

Actio Biosciences is a research center that develops drugs for rare diseases.

Bioinformatics · San Diego$66.0M Series B
UrbanSitter
May 2025

UrbanSitter is an online hub connecting families with babysitters through social networks.

Child Care · San Francisco$2.7M Venture - Series Unknown
Cynomi
April 2025

Cynomi provides an AI platform for automating risk assessments and compliance.

Artificial Intelligence (AI) · Herzliya$37.0M Series B
Vivace Therapeutics
March 2025

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.

Biotechnology · San Mateo$35.0M Series D
Valid
February 2025

The AI-enabled ad agency.

San Francisco$5.5M Seed
Aer Therapeutics
February 2025

Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.

Biotechnology · Raleigh$5.0M Venture - Series Unknown
WiseLayer
January 2025

WiseLayer makes AI-powered digital workers for finance and accounting teams.

Artificial Intelligence (AI) · New York$7.2M Seed
Normunity
January 2025

Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.

Biotechnology · New Haven$75.0M Series B
RenoFi
January 2025

RenoFi helps homeowners discover a smart way to finance their renovation and tackle everything on their wishlist.

Commercial Lending · Philadelphia$1.5M Venture - Series Unknown
Enterpret
December 2024

Enterpret analyzes customer feedback using AI and NLP, offering tailored insights for product growth.

Analytics · San Francisco$20.8M Series A
Nivoda
November 2024

Nivoda is a digital marketplace and supply chain for natural and lab-grown diamonds.

Jewelry · London$51.0M Series C
Treehouse
October 2024

Treehouse is a software-enabled service for home electrification.

Clean Energy · San Francisco$16.6M Series A
Genome Medical
September 2024

Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.

Genetics · South San Francisco$75.3M Venture - Series Unknown
EMTECH
September 2024

EMTECH is a fintech company that modernizes central banks for financial inclusion and resilience.

Big Data · New YorkSeries A
Halda Therapeutics
August 2024

Halda Therapeutics is a research-stage drug discovery company.

Biotechnology · New Haven$126.0M Series B
Aim Security
June 2024

Aim Security is a GenAI security platform that aids enterprises in securing their transformation and increasing business productivity.

Artificial Intelligence (AI) · Tel Aviv$18.0M Series A
Reflex
June 2024

A marketplace connecting retailers with the best flexible retail associates on demand.

Human Resources · Austin$9.1M Seed
Greywolf Therapeutics
May 2024

We are advancing novel antigen modulation technology that controls T cells to guide the immune system.

Biotechnology · Abingdon$50.0M Series B

Where Canaan Partners invests

Artificial Intelligence (AI)6
Biotechnology6
Health Care5
Medical5
Therapeutics5
Software3

About Canaan Partners's portfolio

How many companies has Canaan Partners invested in?▸

Canaan Partners has invested in 269 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Canaan Partners invest in?▸

Canaan Partners's top investment sectors include Artificial Intelligence (AI), Biotechnology, Health Care, Medical, Therapeutics. The firm invests across 52 different industry categories.

What is Canaan Partners's largest investment?▸

Among tracked funding rounds, Halda Therapeutics received $126.0M in a Series B round. Canaan Partners's total known invested capital is $8.1B.

What is the average investment size for Canaan Partners?▸

Canaan Partners's average investment size is $39.5M across its portfolio of 269 companies.

What are Canaan Partners's most recent investments?▸

Recent Canaan Partners portfolio additions include Field AI, Apex.AI, Tropic, Clutch, Journey Live. These companies were founded in 2020 or later.

Reach the founders behind these 269 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →